Azartan Plus F Tablets

Adult dose

The usual dosage for this medication is one tablet of losartan potassium 50 mg / hydrochlorothiazide 12.5 mg once daily. A dose exceeding losartan potassium 100 mg / hydrochlorothiazide 25 mg per day is not desirable. 1. For patients whose blood pressure is not controlled with monotherapy of losartan or hydrochlorothiazide, treatment may start with one tablet of losartan potassium 50 mg / hydrochlorothiazide 12.5 mg once daily.

Child dose

There is no experience in using this medication in children and adolescents, so the losartan-hydrochlorothiazide combination should not be administered to this age group.

This drug can cause serious harm to the fetus and newborn during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. This drug should not be administered to patients with certain diseases or hypersensitivity. For example, caution is necessary for patients with severely impaired kidney function or anuria, or those with specific allergies. It should be administered with caution to patients with hypotension or fluid deficiency as significant blood pressure reduction may occur. Patients with poor liver function, hyperuricemia, diabetes, or cerebrovascular diseases also require special caution when taking this medication. During the use of this medication, electrolytes in the blood, particularly potassium and sodium levels, should be monitored regularly to ensure no abnormalities. The hydrochlorothiazide component may cause photosensitivity reactions and increase the risk of skin cancer, so sun exposure should be minimized, and skin condition should be checked regularly. This drug can interact with a variety of medications, so patients taking other medications should definitely consult their physician or pharmacist. There is a risk of dizziness or drowsiness while driving or operating machinery, so caution is necessary. Breastfeeding women may see adverse reactions in their babies when taking this medication, so it is advisable to stop breastfeeding or discontinue the medication. Safety in children and adolescents has not been established; therefore, this drug is not administered in this age group. Elderly patients may experience adverse reactions more frequently, necessitating careful monitoring during administration. In case of overdose, hypotension or cardiac arrhythmia might occur, so medical personnel should be contacted immediately. Patients should consult with medical personnel regarding pregnancy plans or the status of pregnancy while taking this medication and should not use it during pregnancy.

Serious side effects

Hives, severe swelling (edema), angioedema (swelling of lips and eyelids and facial rash), skin peeling on the palm, hemolysis, angioedema (laryngeal/pharyngeal swelling that can lead to airway obstruction, swelling of face/lips/pharynx/tongue), vasculitis, anaphylaxis, jaundice (intrahepatic cholestatic jaundice), renal failure, hepatitis, cholestasis, acute respiratory distress syndrome (ARDS), acute renal failure, angina, arrhythmia (atrial)

Mild side effects

• Abdominal pain
• swelling
• palpitations
• back pain
• dizziness
• cough
• sinusitis
• upper respiratory infection
• weakness
• fatigue

This medication should be stored in a tightly sealed container to avoid light and air. The storage temperature should be maintained between 1 and 30 degrees Celsius.

Appearance

Yellowish oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle